Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015711
Filing Date
2024-11-14
Accepted
2024-11-14 16:09:08
Documents
80
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hook-20240930x10q.htm   iXBRL 10-Q 1932393
2 EX-31.1 hook-20240930xex31d1.htm EX-31.1 9863
3 EX-31.2 hook-20240930xex31d2.htm EX-31.2 9856
4 EX-32.1 hook-20240930xex32d1.htm EX-32.1 8488
  Complete submission text file 0001558370-24-015711.txt   8080294

Data Files

Seq Description Document Type Size
5 EX-101.SCH hook-20240930.xsd EX-101.SCH 62434
6 EX-101.CAL hook-20240930_cal.xml EX-101.CAL 47575
7 EX-101.DEF hook-20240930_def.xml EX-101.DEF 244091
8 EX-101.LAB hook-20240930_lab.xml EX-101.LAB 494313
9 EX-101.PRE hook-20240930_pre.xml EX-101.PRE 376729
83 EXTRACTED XBRL INSTANCE DOCUMENT hook-20240930x10q_htm.xml XML 1343550
Mailing Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

EIN.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38869 | Film No.: 241462140
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)